HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter ten Dijke Selected Research

Smad7 Protein

4/2013Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis.
2/2003Growth differentiation factor-9 induces Smad2 activation and inhibin B production in cultured human granulosa-luteal cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter ten Dijke Research Topics

Disease

23Neoplasms (Cancer)
01/2016 - 07/2005
10Breast Neoplasms (Breast Cancer)
01/2016 - 02/2006
7Fibrosis (Cirrhosis)
01/2012 - 05/2006
6Neoplasm Metastasis (Metastasis)
11/2013 - 02/2006
4Hereditary Hemorrhagic Telangiectasia
07/2012 - 12/2005
3Colorectal Neoplasms (Colorectal Cancer)
06/2015 - 01/2010
2Pulmonary Arterial Hypertension
02/2016 - 07/2012
2Disease Progression
03/2013 - 01/2012
2Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
02/2013 - 04/2011
2Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
01/2013 - 06/2010
2Pathologic Neovascularization
05/2012 - 01/2010
2Carcinogenesis
01/2010 - 01/2009
2Telangiectasis (Telangiectasia)
01/2008 - 10/2004
2Pre-Eclampsia (Preeclampsia)
01/2008 - 11/2007
2Infarction (Infarctions)
11/2006 - 11/2004
2Myocardial Infarction
11/2006 - 11/2004
1Atherosclerosis
02/2016
1Melanoma (Melanoma, Malignant)
01/2016
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2016
1Microsatellite Instability
06/2015
1Colonic Neoplasms (Colon Cancer)
06/2015
1Stomatitis
04/2013
1Heterotopic Ossification (Ectopic Ossification)
02/2013
1Osteoblastoma
12/2012
1Osteosarcoma (Osteogenic Sarcoma)
12/2012
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2012
1Neuroinflammatory Diseases
04/2012
1Granulosa Cell Tumor
03/2012
1Pneumonia (Pneumonitis)
02/2012
1Hepatocellular Carcinoma (Hepatoma)
01/2012
1Liver Diseases (Liver Disease)
01/2012
1Inflammation (Inflammations)
01/2012
1Thymoma (Thymic Carcinoma)
08/2011
1Cysts
09/2010
1Polycystic Kidney Diseases (Polycystic Kidney Disease)
09/2010
1Autosomal Dominant Polycystic Kidney (ADPKD)
09/2010
1Vascular Malformations
09/2010
1Systemic Scleroderma (Systemic Sclerosis)
08/2008
1Cartilage Diseases (Cartilage Disease)
06/2008
1Osteoarthritis
06/2008
1Vascular Diseases (Vascular Disease)
01/2008
1Arteriovenous Malformations (Arteriovenous Malformation)
01/2008
1Marfan Syndrome (Marfan's Syndrome)
11/2007
1Adenocarcinoma
07/2007

Drug/Important Bio-Agent (IBA)

21Transforming Growth Factor beta (TGF-beta)IBA
11/2013 - 02/2003
12Transforming Growth Factors (Transforming Growth Factor)IBA
06/2015 - 04/2007
10EndoglinIBA
04/2013 - 10/2004
8Activin Receptors (Activin Receptor)IBA
01/2016 - 10/2004
8Proteins (Proteins, Gene)FDA Link
01/2016 - 02/2003
5Phosphotransferases (Kinase)IBA
11/2013 - 11/2007
5Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2010 - 02/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 03/2013
3Pharmaceutical PreparationsIBA
03/2013 - 08/2008
3Transforming Growth Factor-beta Type I ReceptorIBA
09/2010 - 10/2004
2LigandsIBA
02/2016 - 01/2016
2Peptide Hydrolases (Proteases)FDA Link
11/2014 - 11/2013
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2013 - 01/2009
2Smad7 ProteinIBA
04/2013 - 02/2003
2Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
02/2013 - 01/2010
2Type I Bone Morphogenetic Protein ReceptorsIBA
07/2012 - 06/2010
2Interleukin-11 (Interleukin 11)IBA
04/2012 - 02/2006
2CytokinesIBA
02/2012 - 01/2012
2CollagenIBA
08/2011 - 05/2006
2Matrix Metalloproteinase 2 (Gelatinase A)IBA
08/2011 - 09/2010
2Messenger RNA (mRNA)IBA
09/2010 - 11/2004
1Cisplatin (Platino)FDA LinkGeneric
01/2016
1Transforming Growth Factor-beta Type II ReceptorIBA
06/2015
1nutlin 3IBA
11/2014
1Matrix Metalloproteinases (MMPs)IBA
11/2014
1Tumor Suppressor Protein p53IBA
11/2014
1IntegrinsIBA
11/2014
1Cytostatic AgentsIBA
12/2013
1Therapeutic UsesIBA
04/2013
1Keratin-5 (Keratin 5)IBA
04/2013
1Antisense OligonucleotidesIBA
01/2013
1Type II Bone Morphogenetic Protein Receptors (Bone Morphogenetic Protein Receptor Type II)IBA
07/2012
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2012
1InterleukinsIBA
04/2012
1Ion Channels (Ion Channel)IBA
04/2012
1inhibin BIBA
03/2012
1Biological ProductsIBA
03/2012
1DystrophinIBA
04/2011
1MyostatinIBA
04/2011
1Epidermal Growth Factor (EGF)IBA
02/2011
1Collagen Type I (Type I Collagen)IBA
09/2010
1Fibronectins (Fibronectin)IBA
09/2010
1Thalidomide (Thalomid)FDA Link
09/2010
1Plasminogen Activator Inhibitor 1IBA
09/2010
1Phenobarbital (Luminal)FDA Link
09/2010
1Annexin A1IBA
04/2010
1Mesalamine (Mesalazine)FDA LinkGeneric
01/2010
1CarcinogensIBA
01/2009
1Extracellular Matrix ProteinsIBA
11/2008
1Imatinib Mesylate (Gleevec)FDA Link
08/2008
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2008
1AntibodiesIBA
01/2008
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2008

Therapy/Procedure

7Therapeutics
01/2016 - 06/2005
2Ligation
09/2010 - 05/2006
1Drug Therapy (Chemotherapy)
01/2016